Fox Run Management L.L.C. Makes New $418,000 Investment in UnitedHealth Group Incorporated $UNH

Fox Run Management L.L.C. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,339 shares of the healthcare conglomerate’s stock, valued at approximately $418,000.

A number of other large investors have also added to or reduced their stakes in the company. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Glass Jacobson Investment Advisors llc increased its stake in UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after acquiring an additional 55 shares during the last quarter. Kentucky Trust Co lifted its stake in shares of UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Nova Wealth Management Inc. increased its position in shares of UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after purchasing an additional 78 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $339.18 on Thursday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The business’s fifty day simple moving average is $347.08 and its 200-day simple moving average is $320.66. The company has a market capitalization of $307.25 billion, a price-to-earnings ratio of 17.70, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the business earned $7.15 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on UNH shares. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Barclays increased their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Finally, Weiss Ratings raised shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.